Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

The only heart failure treatment of its kind: Learn the latest billing recommendations for Barostim procedures
The Barostim device from CVRx continues to gain momentum as a go-to heart failure treatment. A free webinar is scheduled to examine the device's new CPT codes, which go into effect in 2026.
FDA clears new stent-based coronary thrombectomy system
The newly cleared system offers clinicians a new option for capturing and removing large coronary thrombi in patients undergoing primary PCI.
Telix and Siemens Healthineers partner to advance oncologic therapies
Leaders from both companies are optimistic about how their partnership can improve precision medicine and palliative therapies.
A common word may be giving heart patients the wrong idea
Cardiologists often use the word “stable” when describing a heart failure patient who is recovering or showing signs of improvement. That word, however, could be giving patients a false sense of security—and it could even do harm to their long-term health.
Q&A: Cardiologist reviews key trends in pediatric electrophysiology for 2026 and beyond
Pediatric electrophysiology is an invaluable part of any healthcare system, and its importance is only growing as technologies continue to evolve. We spoke to Nicholas Von Bergen, MD, to learn more about where the specialty is headed in the years ahead.

The only heart failure treatment of its kind: Learn the latest billing recommendations for Barostim procedures

The Barostim device from CVRx continues to gain momentum as a go-to heart failure treatment. A free webinar is scheduled to examine the device's new CPT codes, which go into effect in 2026.

Vesalio enVast coronary mechanical thrombectomy system gained FDA in December 2025.

FDA clears new stent-based coronary thrombectomy system

The newly cleared system offers clinicians a new option for capturing and removing large coronary thrombi in patients undergoing primary PCI.

Telix and Siemens Healthineers partner to advance oncologic therapies

Leaders from both companies are optimistic about how their partnership can improve precision medicine and palliative therapies.

radiology reporting EHR health record CDS AUC

A common word may be giving heart patients the wrong idea

Cardiologists often use the word “stable” when describing a heart failure patient who is recovering or showing signs of improvement. That word, however, could be giving patients a false sense of security—and it could even do harm to their long-term health.

Q&A: Cardiologist reviews key trends in pediatric electrophysiology for 2026 and beyond

Pediatric electrophysiology is an invaluable part of any healthcare system, and its importance is only growing as technologies continue to evolve. We spoke to Nicholas Von Bergen, MD, to learn more about where the specialty is headed in the years ahead.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Is IVL safe for patients with diabetes?

New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.

Arnold Seto, MD, MPA, FACC, FSCAI, cath lab director, Long Beach VA Medical Center, professor of medicine at Charles Drew University, Society for Cardiovascular Angiography and Interventions (SCAI) treasurer and chair of the SCAI Advocacy Committee, explains the new CPT reimbursement codes being introduced in January 2026 and their impact on practice.

CPT code updates in 2026 will change how interventional cardiologists get paid

A variety of CPT code changes take effect in 2026, and many of them will make a direct impact on interventional cardiology. Arnold Seto, MD, spoke to Cardiovascular Business about these updates for a new video interview.

M-TEER still beneficial for high-risk patients with smaller mitral valve areas

Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective.